Home
Concord Biotech Ltd Share Price History
Concord Biotech Ltd
NSE : 19 Feb, 2025
1700-58.4 (-3.3%)
Prev Close
1758.4
Open Price
1754.9
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
645389
Today's High / Low
1754.9 / 1685.0
52 WK High / Low
2664.0 / 1327.1
Market Price of Concord Biotech Ltd
1M
1Y
3Y
5Y
Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2020 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 177.82 |
| YoY Gr. | - |
| Net Profit (Cr.) | 169 |
| BVPS | 809.87 |
Key Financial Parameters
| Parameter | 2020 |
|---|---|
| Return on Capital Emp. % | 23.23 |
| Op. Profit Mgn % | 41.5 |
| Net Profit Mgn % | 29.6 |
| Debt to Equity % | 0.07 |
Latest Shareholding
Promoters Holdings Over Time
About Concord Biotech Ltd
- Concord Biotech Limited was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies.
- Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based bio pharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immunosuppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
- Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products.
Popular Search
FAQs for Concord Biotech Ltd Share Price History
What are the key events that typically impact Concord Biotech Ltd's share price history?
Key events that impact Concord Biotech Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Concord Biotech Ltd's share price history?
Stock splits reduce the nominal price of Concord Biotech Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Concord Biotech Ltd?
Dividends can influence Concord Biotech Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Concord Biotech Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Concord Biotech Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Concord Biotech Ltd’s share price history?
To understand Concord Biotech Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
